
Growth And Investment Opportunities In The AI In Oncology Market 2025-2029: A Global Industry Analysis
Dublin, Oct. 01, 2025 (GLOBE NEWSWIRE) -- The "AI in Oncology Market 2025-2029" has been added to ResearchAndMarkets's offering.
The AI in oncology market is anticipated to expand significantly, with an expected growth of USD 7.54 billion from 2024 to 2029, reflecting a CAGR of 27.8% within the forecast period. This comprehensive analysis highlights key market dimensions, growth drivers, emerging trends, and vendor insights, covering approximately 25 prominent vendors.
Key market dynamics include the increasing volume and complexity of oncological data, a growing emphasis on personalized medicine and precision oncology, alongside rapid advancements in AI and computational infrastructure. These factors are pivotal in driving market expansion.
Emerging trends such as the rise of multimodal AI and integrated diagnostics are catalyzing growth in the AI in oncology market. There is also a burgeoning focus on clinical workflow integration and scalability, with increased regulatory scrutiny and the demand for real-world evidence driving significant market demand.
Utilizing a blend of primary and secondary data from crucial industry players, the report provides an all-encompassing examination of market size, regional segmentation, and vendor landscape, including historical and forecast data.
Market Segmentation Overview:
- By Component:
- Software Solutions Services
- Breast Cancer Lung Cancer Kidney Cancer Others
- Diagnosis Drug Discovery and Development Treatment Planning Prognosis Prediction
- North America Europe APAC South America Middle East and Africa
Report Coverage Areas:
- AI in Oncology Market Sizing AI in Oncology Market Forecast AI in Oncology Market Industry Analysis
A detailed vendor analysis is incorporated to aid clients in enhancing their market positioning.
The report thoroughly evaluates key vendors such as:
- BenevolentAI ConcertAI Inc. F. Hoffmann La Roche Ltd. Freenome Holdings Inc. GE Healthcare Technologies Inc. Google LLC International Business Machines Corp. Koninklijke Philips N.V. Lunit Inc. Microsoft Corp. NVIDIA Corp. Owkin Inc. PAIGE LLC PathAI Inc. Recursion Pharmaceuticals Inc. Siemens Healthineers AG SOPHiA GENETICS Tempus Labs Inc.
The analysis includes insights into forthcoming trends and challenges influencing market growth, providing strategic guidance for leveraging imminent opportunities. The detailed market portrayal arises from a synthesis of extensive data sources, aligned with key performance metrics such as profit, pricing, competition, and promotional activities.
For more information about this report visit
About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
CONTACT: CONTACT: Laura Wood,Senior Press Manager ... For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900
Legal Disclaimer:
MENAFN provides the
information “as is” without warranty of any kind. We do not accept
any responsibility or liability for the accuracy, content, images,
videos, licenses, completeness, legality, or reliability of the information
contained in this article. If you have any complaints or copyright
issues related to this article, kindly contact the provider above.
Most popular stories
Market Research

- Ethereum-Based Defi Crypto Mutuum Finance (MUTM) Reaches 50% Completion In Phase 6
- Casper (CSPR) Is Listed On Gate As Part Of Continued U.S. Market Expansion
- Ethereum-Based Defi Crypto Mutuum Finance (MUTM) Raises Over $16 Million With More Than 720M Tokens Sold
- Tokenfi And New To The Street Announce National Media Partnership To Reach 219M+ Households
- Flexm Recognized As“Highly Commended” In The Regtech Category At The Asia Fintech Awards Singapore 2025
- Forex Expo Dubai 2025 Conference To Feature 150+ Global FX And Fintech Leaders
Comments
No comment